Bulk Suggestion
Bulk ID:
braviboron/05.20.25-02:07AM
Accepted at: Jun, 06, 2025
12:05 a.m.
Author:
braviboron
Related Deck:
1675118865074
Accepted
Rationale for new note
Psoriasis. This completes the PassMed content, though I used eTG as the main source where possible.
Text
What percentage of patients with psoriasis develop psoriatic arthropathy?
{{c1::Around 10%}}
{{c1::Around 10%}}
Text
What percentage of patients with <b>psoriasis </b>develop <u>psoriatic arthropathy</u>?<br><br>{{c1::Around 10%}}
Extra
Empty field
Extra
Extra (Synced)
Empty field
Extra (Synced)
Personal Notes
Empty field
Personal Notes
Missed Questions
Empty field
Missed Questions
eTG Complete
eTG Complete
<img src="1635434b32327f0044275c7988fc09c5.webp">
Talley & O'Connor
Empty field
Talley & O'Connor
Additional Resources
eTG - Psoriatic arthritis https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Dermatology&topicfile=c_DMG_Considerations-in-the-use-of-topical-corticosteroids_topic_1&guidelinename=auto§ionId=c_DMG_Psoriasis_topic_3#c_DMG_Psoriasis_topic_3 Published/Amended February 2025, Accessed 20 May 2025
Additional Resources
eTG - Psoriatic arthritis <a href="https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Dermatology&topicfile=c_DMG_Considerations-in-the-use-of-topical-corticosteroids_topic_1&guidelinename=auto%C2%A7ionId=c_DMG_Psoriasis_topic_3#c_DMG_Psoriasis_topic_3">https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Dermatology&topicfile=c_DMG_Considerations-in-the-use-of-topical-corticosteroids_topic_1&guidelinename=auto&sectionId=c_DMG_Psoriasis_topic_3#c_DMG_Psoriasis_topic_3</a> Published/Amended February 2025, Accessed 20 May 2025
Additional Resources (Synced)
Empty field
Additional Resources (Synced)
Source
Psoriasis. PassMedicine. Accessed May 2025. https://passmedicine.com
Source
Psoriasis. PassMedicine. Accessed May 2025. <a href="https://passmedicine.com/menu.php?revise=all">https://passmedicine.com</a>
One by one
Empty field
One by one
Tags
#Malleus_CM::#eTG_Complete::Rheumatology::Spondyloarthritis::Psoriatic_arthritis
#Malleus_CM::#Resources_by_Rotation::Dermatology
#Malleus_CM::#Resources_by_Rotation::General_Practice
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::General_Medicine
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Immunology
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Rheumatology
#Malleus_CM::#Resources_by_Rotation::Paediatrics
#Malleus_CM::#Resources_by_Rotation::Surgery::Orthopaedic_Surgery
#Malleus_CM::#Subjects::Dermatology::03_Psoriasis::Psoriasis::11_Complications/Prognosis
#Malleus_CM::#Subjects::Neurology_&_Special_Senses::04_Spinal_Cord_Disorders::*General::Back_Pain_Differentials::Inflammatory_Causes
#Malleus_CM::#Subjects::Orthopaedics_&_Rheumatology::02_Pathology::02_Joint::Seronegative_Spondyloarthritis::Psoriatic_Arthritis::03_Risk_Factors
#Malleus_CM::#Subjects::Paediatrics::02_Dermatology::Psoriasis::11_Complications/Prognosis